Price is syncing
Reported smart-money activity is still available below.
1 month
+0.6%
price return
Year to date
+9.0%
price return
Recent earnings
2/4
quarters beat
News tone
Bullish
18 articles, 7 days
Filed positions and reported activity tied to this stock.
Real smart money
Insiders
Sells (5)
Recent coverage and its overall tone.
News
Coverage is bullish
16 bullish · 2 neutral · 0 bearish
Tone of tracked coverage
Belite Bio Inc (BLTE) Earnings Forecast: Future EPS & Revenue Growth Estimates
BullishJul 25Belite Bio (BLTE) Leerink’s Global Healthcare Conference 2025 Summary
BullishJul 23Belite Bio Conference Highlights Tinlarebant Data and New Hope for Retinal Diseases
Leans bullishJul 22Belite Bio stock price target maintained at $200 by H.C. Wainwright
BullishJul 22Belite Bio stock price target maintained at $200 by H.C. Wainwright
BullishJul 22Belite Bio stock price target maintained at $200 by H.C. Wainwright By Investing.com
BullishJul 22Belite Bio, Inc (BLTE) Stock Analysis: A 37.73% Upside Potential in the Biotechnology Sector
BullishJul 22Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1
BullishJul 21
AlphaYou